Connected for a Cure: Precision Oncology in the Age of AI and Data-Driven Collaboration
Join a conversation with Allan Jordan (VP of Oncology, Sygnature Discovery) and Alister Campbell (VP of Science & Technology, Dotmatics), hosted by Lauren Brown (Senior Account Executive, Dotmatics).
Together, they explore how oncology research is evolving in the face of AI, data deluge, and global collaboration, highlighting real-world lessons from leading research partnerships and what it takes to transform insights into impact in today’s landscape.
Designed for biotech and pharma leaders, this session focuses on how to operationalise data-driven R&D and bring AI-readiness to the front lines of drug discovery.
Key Takeaways
Data as the Differentiator: Why high-quality, accessible, and centralized data is now a prerequisite for therapeutic innovation.
Collaboration Without Compromise: How cross-organizational data sharing is fueling breakthroughs once thought impossible, like targeting KRAS.
AI with Impact: Real-world examples of how AI is accelerating the drug design cycle, optimizing trial matching, and reshaping early diagnosis.
AI-Ready Infrastructure: What your organization needs today to ensure tomorrow’s success—from clinical pipelines to internal decision-making.
Secure your spot for this discussion on the future of oncology R&D. Gain clarity on how leading teams are using collaborative data and AI to move faster, smarter, and more effectively toward treating the most complex diseases of our time.